Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Geriatrics ; (12): 42-46, 2019.
Article in Chinese | WPRIM | ID: wpr-734510

ABSTRACT

Objective To investigate the effect of estrogen receptor-α gene polymorphism on osteoprotegerin(OPG)and calcaneus bone density in early and late postmenopausal women in Guangxi Zhuang nationality,in order to provide the theoretical basis for the early prevention and treatment of postmenopausal osteoporosis caused by estrogen receptor gene-induced osteoprotegerin reduction.Methods The broadband ultrasound attenuation in the right heel bone was measured by quantitative ultrasound bone densitometry in 621 postmenopausal women of Guangxi Zhuang nationality.Peripheral blood mononuclear cells and their DNA were extracted.Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to detect the estrogen receptor-α gene polymorphism.Serum osteoprotegerin level was determined by enzyme-linked immunosorbent assay.The differences of data distribution of OPG and calcaneus bone density were compared between five items of 3 genotypes and 2 alleles at the same age group of 40-,45-,50-,55-,60-,65-,70-,75-80 years.Results Women aged 60 years and over versus those aged 40-59 years showed that serum osteoprotegerin (OPG) and bone mineral density (BMD) were decreased (P < 0.05),and had no significant difference among allele P,p,genotype Pp,pp,PP of ER-α Puv-Ⅱ polymorphism at the same age groups(P>0.05).Women aged 60 years and over showed that ER-α Puv Ⅱ polymorphism of allele big P versus p,Pp,pp,PP in the same age groups had significantly decreased serum osteoprotegerin and bone mineral density.Women aged 65 years and over showed that ER-α Xba Ⅰ polymorphism of heterozygote Xx versus xx,XX,X,x in the same age groups had a significantly increased serum osteoprotegerin and bone mineral density(P<0.05).Conclusions Women with big P allele of ER-a Pvu Ⅱ polymorphism have low serum osteoprotegerin level and a decreased bone mineral density,who are prone to postmenopausal osteoporosis.Thus,P allele of ER-α Pvu Ⅱ polymorphism is a causative agent.More attention should be paid to early prevention and treatment.But,women with the Xx heterozygote of ER-α Xba Ⅰ polymorphism have high serum osteoprotegerin level and an increased bone mineral density,who are not easy to suffer from postmenopausal osteoporosis.Therefore,Xx heterozygote of ER-α Xba Ⅰ polymorphism is a protective agent.The prevention and treatment of postmenopausal osteoporosis should be individualized based on estrogen receptor-α gene polymorphism.

2.
Journal of China Medical University ; (12): 449-452,462, 2017.
Article in Chinese | WPRIM | ID: wpr-608710

ABSTRACT

Objective To explore the effect of dexamethasone(Dex)treatment on the expression of interleukin(IL)?6 and IL?8 in human peri?odontal ligament cells(hPDLCs). Methods hPDLCs were subjected to one of the following treatments for 24 h or 48 h:10-9 mol/L Dex;10-6 mol/L Dex;10μg/mL Porphyromonas gingivalis(P. g)?lipopolysaccharide(LPS);10-9 mol/L Dex+10μg/mL P. g?LPS;10-6 mol/L Dex+10μg/mL P. g?LPS;or 0.1%absolute ethyl alcohol(control). Protein and mRNA expression was detected using ELISA and real?time PCR ,respectively. Results At 24 h and at 48 h,IL?6 and IL?8 protein expression in the 10-9 mol/L Dex?and 10-6 mol/L Dex?treated groups was significantly lower than that in the control group(P<0.05). At 48 h,IL?6 mRNA expression in the 10-9 mol/L Dex?and 10-6 mol/L Dex?treated groups was signifi?cantly lower than that in the control group(P<0.05),while IL?8 mRNA expression in the 10-6 mol/L Dex?treated group was significantly higher than that in the control group(P<0.05). At 24 h and at 48 h,IL?6 protein and mRNA expression in the 10-9 mol/L Dex+10μg/mL P. g?LPS?treated group and the 10-6 mol/L Dex+10μg/mL P. g?LPS?treated group was significantly lower than that in the 10μg/mL P. g?LPS?treated group (P<0.05). At 24 h,IL?8 protein expression in the 10-9 mol/L Dex+10μg/mL P. g?LPS?treated group and the 10-6 mol/L Dex+10μg/mL P. g?LPS?treated group was significantly lower than that in the 10μg/mL P. g?LPS?treated group(P<0.05),while no such significant difference exist?ed at 48 h. At 48 h,IL?8 mRNA expression in the 10-6 mol/L Dex+10μg/mL P. g?LPS?treated group was significantly higher than that in the 10μg/mL P. g?LPS?treated group(P<0.05). Conclusion Dex inhibits the innate and P. g?LPS?induced expression of IL?6 in hPDLCs. However, Dex exerts profound effects on IL?8 expression,and treatment with high doses of Dex may promote IL?8 expression over an extended period.

SELECTION OF CITATIONS
SEARCH DETAIL